1971 related articles for article (PubMed ID: 12079865)
41. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat.
Wang Q; Bing C; Al-Barazanji K; Mossakowaska DE; Wang XM; McBay DL; Neville WA; Taddayon M; Pickavance L; Dryden S; Thomas ME; McHale MT; Gloyer IS; Wilson S; Buckingham R; Arch JR; Trayhurn P; Williams G
Diabetes; 1997 Mar; 46(3):335-41. PubMed ID: 9032086
[TBL] [Abstract][Full Text] [Related]
42. Leptin regulation of neuroendocrine systems.
Ahima RS; Saper CB; Flier JS; Elmquist JK
Front Neuroendocrinol; 2000 Jul; 21(3):263-307. PubMed ID: 10882542
[TBL] [Abstract][Full Text] [Related]
43. Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications.
Bray GA
Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S8-17. PubMed ID: 10997600
[TBL] [Abstract][Full Text] [Related]
44. The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks.
Campfield LA; Smith FJ; Burn P
Horm Metab Res; 1996 Dec; 28(12):619-32. PubMed ID: 9013731
[TBL] [Abstract][Full Text] [Related]
45. The hypothalamus and the control of energy homeostasis: different circuits, different purposes.
Williams G; Bing C; Cai XJ; Harrold JA; King PJ; Liu XH
Physiol Behav; 2001; 74(4-5):683-701. PubMed ID: 11790431
[TBL] [Abstract][Full Text] [Related]
46. Central nervous system and body weight regulation.
Rohner-Jeanrenaud E; Jeanrenaud B
Ann Endocrinol (Paris); 1997; 58(2):137-42. PubMed ID: 9239233
[TBL] [Abstract][Full Text] [Related]
47. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
Raposinho PD; White RB; Aubert ML
J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
[TBL] [Abstract][Full Text] [Related]
48. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
[TBL] [Abstract][Full Text] [Related]
49. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
[TBL] [Abstract][Full Text] [Related]
50. [Leptin].
Nedvídková J
Cesk Fysiol; 1997 Dec; 46(4):182-8. PubMed ID: 9601742
[TBL] [Abstract][Full Text] [Related]
51. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system.
Hoggard N; Hunter L; Duncan JS; Rayner DV
J Mol Endocrinol; 2004 Feb; 32(1):145-53. PubMed ID: 14765998
[TBL] [Abstract][Full Text] [Related]
52. Effects of leptin on melanin-concentrating hormone expression in the brain of lean and obese Lep(ob)/Lep(ob) mice.
Huang Q; Viale A; Picard F; Nahon J; Richard D
Neuroendocrinology; 1999 Mar; 69(3):145-53. PubMed ID: 10087446
[TBL] [Abstract][Full Text] [Related]
53. Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance.
Savontaus E; Pesonen U; Rouru J; Huupponen R; Koulu M
Eur J Pharmacol; 1998 Apr; 347(2-3):265-74. PubMed ID: 9653893
[TBL] [Abstract][Full Text] [Related]
54. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.
Tschöp M; Statnick MA; Suter TM; Heiman ML
Endocrinology; 2002 Feb; 143(2):558-68. PubMed ID: 11796511
[TBL] [Abstract][Full Text] [Related]
55. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
56. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin.
Elmquist JK
Physiol Behav; 2001; 74(4-5):703-8. PubMed ID: 11790432
[TBL] [Abstract][Full Text] [Related]
57. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats.
Adage T; Scheurink AJ; de Boer SF; de Vries K; Konsman JP; Kuipers F; Adan RA; Baskin DG; Schwartz MW; van Dijk G
J Neurosci; 2001 May; 21(10):3639-45. PubMed ID: 11331393
[TBL] [Abstract][Full Text] [Related]
58. Appetite control and reproduction: leptin and beyond.
Small CJ; Stanley SA; Bloom SR
Semin Reprod Med; 2002 Nov; 20(4):389-98. PubMed ID: 12536362
[TBL] [Abstract][Full Text] [Related]
59. Insulin and leptin as adiposity signals.
Benoit SC; Clegg DJ; Seeley RJ; Woods SC
Recent Prog Horm Res; 2004; 59():267-85. PubMed ID: 14749506
[TBL] [Abstract][Full Text] [Related]
60. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans.
Clapham JC; Smith SA; Moore GB; Hughes MG; Azam H; Scott A; Jung RT
Int J Obes Relat Metab Disord; 1997 Mar; 21(3):179-83. PubMed ID: 9080255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
